@article{ab612c3b38d742a3a837f52977acc02f,
title = "The Y deletion gr/gr and susceptibility to testicular germ cell tumor",
abstract = "Testicular germ cell tumor (TGCT) is the most common cancer in young men. Despite a considerable familial component to TGCT risk, no genetic change that confers increased risk has been substantiated to date. The human Y chromosome carries a number of genes specifically involved in male germ cell development, and deletion of the AZFc region at Yq11 is the most common known genetic cause of infertility. Recently, a 1.6-Mb deletion of the Y chromosome that removes part of the AZFc region--known as the {"}gr/gr{"} deletion--has been associated with infertility. In epidemiological studies, male infertility has shown an association with TGCT that is out of proportion with what can be explained by tumor effects. Thus, we hypothesized that the gr/gr deletion may be associated with TGCT. Using logistic modeling, we analyzed this deletion in a large series of TGCT cases with and without a family history of TGCT. The gr/gr deletion was present in 3.0% (13/431) of TGCT cases with a family history, 2% (28/1,376) of TGCT cases without a family history, and 1.3% (33/2,599) of unaffected males. Presence of the gr/gr deletion was associated with a twofold increased risk of TGCT (adjusted odds ratio [aOR] 2.1; 95% confidence interval [CI] 1.3-3.6; P = .005) and a threefold increased risk of TGCT among patients with a positive family history (aOR 3.2; 95% CI 1.5-6.7; P = .0027). The gr/gr deletion was more strongly associated with seminoma (aOR 3.0; 95% CI 1.6-5.4; P = .0004) than with nonseminoma TGCT (aOR 1.5; 95% CI 0.72-3.0; P = .29). These data indicate that the Y microdeletion gr/gr is a rare, low-penetrance allele that confers susceptibility to TGCT.",
keywords = "Alleles, Chromosomes, Human, Y/chemistry, Confidence Intervals, Gene Deletion, Genetic Predisposition to Disease, Humans, Infertility, Male, Linear Models, Male, Odds Ratio, Pedigree, Penetrance, Risk, Seminoma/genetics, Testicular Neoplasms/genetics",
author = "Nathanson, {Katherine L} and Kanetsky, {Peter A} and Rachel Hawes and Vaughn, {David J} and Richard Letrero and Kathy Tucker and Michael Friedlander and Kelly-Anne Phillips and David Hogg and Jewett, {Michael A S} and Radka Lohynska and Gedske Daugaard and St{\'e}phane Richard and Agn{\'e}s Chompret and Catherine Bona{\"i}ti-Pelli{\'e} and Axel Heidenreich and Edith Olah and Lajos Geczi and Istvan Bodrogi and Ormiston, {Wilma J} and Daly, {Peter A} and Oosterhuis, {J Wolter} and Gillis, {Ad J M} and Looijenga, {Leendert H J} and Parry Guilford and Foss{\aa}, {Sophie D} and Ketil Heimdal and Tjulandin, {Sergei A} and Ludmila Liubchenko and Hans Stoll and Walter Weber and Matthew Rudd and Robert Huddart and Crockford, {Gillian P} and David Forman and Oliver, {D Timothy} and Lawrence Einhorn and Weber, {Barbara L} and Joan Kramer and Mary McMaster and Greene, {Mark H} and Malcolm Pike and Victoria Cortessis and Chu Chen and Schwartz, {Stephen M} and Bishop, {D Timothy} and Easton, {Douglas F} and Stratton, {Michael R} and Rapley, {Elizabeth A}",
note = "Funding Information: Supported by grants from the University of Pennsylvania Research Foundation, the Abramson Cancer Center at the University of Pennsylvania, and the Lance Armstrong Foundation (to K.L.N.); Cancer Research UK program grant (to E.A.R., M.R.S., D.F.E., D.T.B., and G.P.C.); Hungarian research grants OTKA T030039 and OM Szechenyi NKFP/1/48/2001 (to E.O.); National Cancer Institute grants R01CA085914 and R01 CA10204 (to S.M.S. and V.C., respectively); Comit{\'e} du Cher de la Ligue Nationale contre le Cancer (to S.R.); California Cancer Research Program grant 99-00505V-10260 (to V.C.); and The Dutch Cancer Society (to J.W.O., A.J.M.G., and L.H.J.L.) Funding Information: The collection of cancer incidence data in the University of Southern California component of this study was supported by the California Department of Health Services as part of the statewide cancer reporting program mandated by California Health and Safety Code Section 103885; the National Cancer Institute's Surveillance, Epidemiology and End Results Program; and the Centers for Disease Control and Prevention National Program of Cancer Registries. The ideas and opinions expressed herein are those of the authors, and endorsement by the California Department of Health Services, the National Cancer Institute, and the Centers for Disease Control and Prevention is not intended nor should be inferred. ",
year = "2005",
month = dec,
doi = "10.1086/498455",
language = "English",
volume = "77",
pages = "1034--43",
journal = "American journal of human genetics",
issn = "0002-9297",
publisher = "Cell Press",
number = "6",
}